Suppr超能文献

分层结构的可生物降解微球促进治疗性血管生成。

Hierarchically Structured Biodegradable Microspheres Promote Therapeutic Angiogenesis.

作者信息

Hendow Eseelle K, Iacoviello Francesco, Casajuana Ester Mar, Pellet-Many Caroline, Day Richard M

机构信息

Centre for Precision Healthcare, UCL Division of Medicine, University College London, Gower Street, London, WC1E 6BT, UK.

Electrochemical Innovation Lab, UCL Department of Chemical Engineering, University College London, Roberts Building, London, WC1E 7JE, UK.

出版信息

Adv Healthc Mater. 2024 Dec;13(31):e2401832. doi: 10.1002/adhm.202401832. Epub 2024 Sep 11.

Abstract

Promoting neovascularization is a prerequisite for many tissue engineering applications and the treatment of cardiovascular disease. Delivery of a pro-angiogenic stimulus via acellular materials offers several benefits over biological therapies but has been hampered by interaction of the implanted material with the innate immune response. However, macrophages, a key component of the innate immune response, release a plurality of soluble factors that can be harnessed to stimulate neovascularization and restore blood flow to damaged tissue. This study investigates the ability of biodegradable poly(D,L-lactic-co-glycolic acid) (PLGA) microspheres to restore tissue perfusion in a hind limb model of ischaemia. Microspheres exhibiting a hierarchical porous structure are associated with an increase in blood flow at day 21 post-implantation compared with solid microspheres composed of the same polymer. This corresponds with an increase in blood vessel density in the surrounding tissue. In vitro simulation of the foreign body response observed demonstrates M2-like macrophages incubated with the porous microspheres secreted increased amounts of vascular endothelial growth factor (VEGF) compared with M1-like macrophages providing a potential mechanism for the increased neovascularization. The results from this study demonstrate implantable biodegradable porous microspheres provide a novel approach for increasing neovascularization that could be exploited for therapeutic applications.

摘要

促进血管新生是许多组织工程应用和心血管疾病治疗的先决条件。通过无细胞材料递送促血管生成刺激物比生物疗法具有若干优势,但植入材料与先天免疫反应的相互作用阻碍了其发展。然而,巨噬细胞作为先天免疫反应的关键组成部分,会释放多种可溶性因子,可利用这些因子来刺激血管新生并恢复受损组织的血流。本研究调查了可生物降解的聚(D,L-乳酸-共-乙醇酸)(PLGA)微球在缺血后肢模型中恢复组织灌注的能力。与由相同聚合物组成的实心微球相比,具有分级多孔结构的微球在植入后第21天与血流量增加相关。这与周围组织中血管密度的增加相对应。观察到的体外异物反应模拟表明,与M1样巨噬细胞相比,与多孔微球孵育的M2样巨噬细胞分泌的血管内皮生长因子(VEGF)量增加,这为增加血管新生提供了潜在机制。这项研究的结果表明,可植入的可生物降解多孔微球为增加血管新生提供了一种新方法,可用于治疗应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9579/11650400/af542a5db9ad/ADHM-13-0-g006.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验